The Psychiatric Biomarkers Network (PBN) (https://psychiatricbiomarkers.org/) is a consortium of academic and industry partners seeking to discover fluid molecular biomarkers for schizophrenia and bipolar disorder, to enable more efficient and effective drug development for these pharmacologically u